| |
|
|
|
|
|
|
|||
|
Blood, 1 April 2006, Vol. 107, No. 7, pp. 2806-2813. Prepublished online as a Blood First Edition Paper on December 8, 2005; DOI 10.1182/blood-2005-08-3255.
Submitted August 11, 2005
Cancer Sciences Division, Molecular Immunology Group, Southampton University Hospitals Trust, Southampton, Hampshire, United Kingdom * Corresponding author; email: fs{at}soton.ac.uk.
Human subjects maintain long-term immunological memory against infective organisms but the mechanism is unclear. CD4+ Th memory cells (Thmem) are pivotal in controlling humoral and cellular responses, therefore their longevity and response to vaccination are critical for maintenance of protective immunity. To probe the dynamics of Thmem response, to antigenic challenge, we investigated subjects following a booster injection with tetanus toxoid (TT). Expansion of TT-specific Thmem, and cytokine production, showed complex kinetics. Strikingly, parallel expansion and cytokine production occurred in pre-existing Thmem cells specific for two other common antigens, Purified Protein Derivative of tuberculin, and Candida albicans. Bystander expansion occurred in Thmem but not in Th naive cells. Antibody production against TT peaked ~2 weeks post-vaccination and gradually declined. However, pre-existing antibody against the other antigens did not change. It appears that, although all Thmem cells are readily stimulated to expand, antibody responses are controlled by antigen availability. These findings relate to the maintenance of memory, and have consequences for assessments of specific T-cell responses to vaccination.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||